StonvexLoading…
StonvexCore line items from ERIE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.07B | $3.80B | $3.27B | $2.84B |
Operating Income | $717.18M | $676.46M | $520.26M | $376.21M |
Net Income | $559.34M | $600.31M | $446.06M | $298.57M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $3.36B | $2.89B | $2.47B | $2.24B |
Total Liabilities | $1.07B | $901.36M | $809.13M | $791.05M |
Cash & Equivalents | $345.87M | $298.40M | $144.06M | $142.09M |
Free Cash Flow OCF − CapEx | $570.97M | $486.40M | $288.56M | $298.95M |
Shares Outstanding | Not available | Not available | Not available | Not available |